166 related articles for article (PubMed ID: 18751372)
21. The expression of prostate stem cell antigen in human clear cell renal cell carcinoma: a quantitative reverse transcriptase-polymerase chain reaction analysis.
Elsamman EM; Fukumori T; Tanimoto S; Nakanishi R; Takahashi M; Toida K; Kanayama HO
BJU Int; 2006 Sep; 98(3):668-73. PubMed ID: 16925770
[TBL] [Abstract][Full Text] [Related]
22. Increased mRNA expression of ADAMs in renal cell carcinoma and their association with clinical outcome.
Roemer A; Schwettmann L; Jung M; Roigas J; Kristiansen G; Schnorr D; Loening SA; Jung K; Lichtinghagen R
Oncol Rep; 2004 Feb; 11(2):529-36. PubMed ID: 14719095
[TBL] [Abstract][Full Text] [Related]
23. Decreased expression of Annexin A1 correlates with pathologic differentiation grade in oral squamous cell carcinoma.
Zhang L; Yang X; Zhong LP; Zhou XJ; Pan HY; Wei KJ; Li J; Chen WT; Zhang ZY
J Oral Pathol Med; 2009 Apr; 38(4):362-70. PubMed ID: 18673418
[TBL] [Abstract][Full Text] [Related]
24. Differential protein profiling in renal-cell carcinoma.
Shi T; Dong F; Liou LS; Duan ZH; Novick AC; DiDonato JA
Mol Carcinog; 2004 May; 40(1):47-61. PubMed ID: 15108329
[TBL] [Abstract][Full Text] [Related]
25. Increased RANKL expression is related to tumour migration and metastasis of renal cell carcinomas.
Mikami S; Katsube K; Oya M; Ishida M; Kosaka T; Mizuno R; Mochizuki S; Ikeda T; Mukai M; Okada Y
J Pathol; 2009 Aug; 218(4):530-9. PubMed ID: 19455604
[TBL] [Abstract][Full Text] [Related]
26. Detection of transcript for brain-type fatty Acid-binding protein in tumor and urine of patients with renal cell carcinoma.
Teratani T; Domoto T; Kuriki K; Kageyama T; Takayama T; Ishikawa A; Ozono S; Nozawa R
Urology; 2007 Feb; 69(2):236-40. PubMed ID: 17320655
[TBL] [Abstract][Full Text] [Related]
27. Expression of regulator of G protein signalling protein 5 (RGS5) in the tumour vasculature of human renal cell carcinoma.
Furuya M; Nishiyama M; Kimura S; Suyama T; Naya Y; Ito H; Nikaido T; Ishikura H
J Pathol; 2004 May; 203(1):551-8. PubMed ID: 15095478
[TBL] [Abstract][Full Text] [Related]
28. Expression of heparanase in renal cell carcinomas: implications for tumor invasion and prognosis.
Mikami S; Oya M; Shimoda M; Mizuno R; Ishida M; Kosaka T; Mukai M; Nakajima M; Okada Y
Clin Cancer Res; 2008 Oct; 14(19):6055-61. PubMed ID: 18809970
[TBL] [Abstract][Full Text] [Related]
29. [mRNA expression analysis of metastatic markers in clear-cell renal cell carcinoma].
Struckmann K; Mertz K; Staller P; Krek W; Schraml P; Moch H
Verh Dtsch Ges Pathol; 2005; 89():178-83. PubMed ID: 18035688
[TBL] [Abstract][Full Text] [Related]
30. Genome-wide gene expression profiles of clear cell renal cell carcinoma: identification of molecular targets for treatment of renal cell carcinoma.
Hirota E; Yan L; Tsunoda T; Ashida S; Fujime M; Shuin T; Miki T; Nakamura Y; Katagiri T
Int J Oncol; 2006 Oct; 29(4):799-827. PubMed ID: 16964377
[TBL] [Abstract][Full Text] [Related]
31. CD147 and VEGF expression in advanced renal cell carcinoma and their prognostic value.
Liang YX; He HC; Han ZD; Bi XC; Dai QS; Ye YK; Qin WJ; Zeng GH; Zhu G; Xu CL; Zhong WD
Cancer Invest; 2009 Aug; 27(7):788-93. PubMed ID: 19548138
[TBL] [Abstract][Full Text] [Related]
32. Overexpression of Csk-binding protein contributes to renal cell carcinogenesis.
Feng X; Lu X; Man X; Zhou W; Jiang LQ; Knyazev P; Lei L; Huang Q; Ullrich A; Zhang Z; Chen Z
Oncogene; 2009 Sep; 28(37):3320-31. PubMed ID: 19581936
[TBL] [Abstract][Full Text] [Related]
33. Upregulation of GRP78 in renal cell carcinoma and its significance.
Fu W; Wu X; Li J; Mo Z; Yang Z; Huang W; Ding Q
Urology; 2010 Mar; 75(3):603-7. PubMed ID: 19616278
[TBL] [Abstract][Full Text] [Related]
34. BIGH3 is overexpressed in clear cell renal cell carcinoma.
Yamanaka M; Kimura F; Kagata Y; Kondoh N; Asano T; Yamamoto M; Hayakawa M
Oncol Rep; 2008 Apr; 19(4):865-74. PubMed ID: 18357369
[TBL] [Abstract][Full Text] [Related]
35. Down-regulation of PKCζ in renal cell carcinoma and its clinicopathological implications.
Pu YS; Huang CY; Chen JY; Kang WY; Lin YC; Shiu YS; Chuang SJ; Yu HJ; Lai MK; Tsai YC; Wu WJ; Hour TC
J Biomed Sci; 2012 Apr; 19(1):39. PubMed ID: 22475628
[TBL] [Abstract][Full Text] [Related]
36. Expression of DLC-1 in clear cell renal cell carcinoma: prognostic significance for progression and metastasis.
Zhang T; Zheng J; Liu C; Lu Y
Urol Int; 2009; 82(4):380-7. PubMed ID: 19506402
[TBL] [Abstract][Full Text] [Related]
37. Identification of protein-coding and intronic noncoding RNAs down-regulated in clear cell renal carcinoma.
Brito GC; Fachel AA; Vettore AL; Vignal GM; Gimba ER; Campos FS; Barcinski MA; Verjovski-Almeida S; Reis EM
Mol Carcinog; 2008 Oct; 47(10):757-67. PubMed ID: 18348187
[TBL] [Abstract][Full Text] [Related]
38. In search of suitable reference genes for gene expression studies of human renal cell carcinoma by real-time PCR.
Jung M; Ramankulov A; Roigas J; Johannsen M; Ringsdorf M; Kristiansen G; Jung K
BMC Mol Biol; 2007 Jun; 8():47. PubMed ID: 17559644
[TBL] [Abstract][Full Text] [Related]
39. [Expression of SSX2 gene in human urologic neoplasms].
Du P; Yu LZ; Ma M; Geng L; Wang XS; Xin DQ; Na YQ
Zhonghua Wai Ke Za Zhi; 2005 Mar; 43(6):379-81. PubMed ID: 15854347
[TBL] [Abstract][Full Text] [Related]
40. [Activation of RHOA gene transcription in epithelial tumors may be caused by gene amplification and/or demethylation of its promotor region].
Braga EA; Loginov VI; Klimov EA; Kilosanidze G; Khodyrev DS; Kaganova NL; Kazybskaia TP; Ermilova VD; Gar'kavtseva RF; Pronina IV; Rud'ko OI; Zabarskiĭ ER; Sulimova GE; Kiselev LL
Mol Biol (Mosk); 2006; 40(5):865-77. PubMed ID: 17086988
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
